We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+31.28%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.82B
AUM Growth
+$324M
Cap. Flow
-$120M
Cap. Flow %
-6.62%
Top 10 Hldgs %
36.31%
Holding
2,419
New
1,036
Increased
430
Reduced
305
Closed
497

Top Buys

Rank Stock Value
1
SHYG icon
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
+$24M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$7.59M
3
CZR
Caesars Entertainment Corporation
CZR
+$5.85M
4
AVGO icon
Broadcom
AVGO
+$5.1M
5
ACIA
Acacia Communications Inc
ACIA
+$3.72M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$16.1M
2
WBC
WABCO HOLDINGS INC.
WBC
+$11.4M
3
FTSV
Forty Seven, Inc. Common Stock
FTSV
+$11.3M
4
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$10.3M
5
MU icon
Micron Technology
MU
+$8.71M

Sector Composition

Rank Sector Weight
1 Technology 6.98%
2 Consumer Discretionary 5.02%
3 Healthcare 3.42%
4 Financials 2.97%
5 Industrials 2.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SAVE
1751
DELISTED
Spirit Airlines, Inc.
SAVE
$4K ﹤0.01%
+200
New +$2.85K
SPWR
1752
CALL
DELISTED
SunPower Corporation Common Stock
SPWR
$4K ﹤0.01%
+764
New +$3.49K
AVTA
1753
DELISTED
Avantax, Inc. Common Stock
AVTA
$4K ﹤0.01%
324
-3,394
-91% -$42.6K
PRTK
1754
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$4K ﹤0.01%
+756
New +$3.36K
SRNE
1755
PUT
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$4K ﹤0.01%
+700
New +$2.68K
PTE
1756
DELISTED
PolarityTE, Inc. Common Stock
PTE
$4K ﹤0.01%
+131
New +$3.48K
TBIO
1757
CALL
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$4K ﹤0.01%
+200
New +$3.02K
MSGN
1758
DELISTED
MSG Networks Inc.
MSGN
$4K ﹤0.01%
+400
New +$4.57K
FIT
1759
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
$4K ﹤0.01%
600
-10,000
-94% -$65.3K
TCO
1760
CALL
DELISTED
Taubman Centers Inc.
TCO
$4K ﹤0.01%
+100
New +$4.09K
PTLA
1761
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$4K ﹤0.01%
+200
New +$2.78K
AHT
1762
Ashford Hospitality Trust
AHT
$21M
$3K ﹤0.01%
+4
New +$3.1K
AMRC icon
1763
Ameresco
AMRC
$1.36B
$3K ﹤0.01%
+100
New +$2.02K
ATRO icon
1764
Astronics
ATRO
$3.84B
$3K ﹤0.01%
+360
New +$2.81K
AXGN icon
1765
Axogen
AXGN
$2.5B
$3K ﹤0.01%
300
+200
+200% +$1.79K
CANE icon
1766
Teucrium Sugar Fund
CANE
$53M
$3K ﹤0.01%
+500
New +$2.75K
CANE icon
1767
PUT
Teucrium Sugar Fund
CANE
$53M
$3K ﹤0.01%
+500
New +$2.75K
CLMB icon
1768
Climb Global Solutions
CLMB
$519M
$3K ﹤0.01%
+400
New +$1.9K
CTMX icon
1769
CytomX Therapeutics
CTMX
$754M
$3K ﹤0.01%
+400
New +$3.71K
ET icon
1770
CALL
Energy Transfer Partners
ET
$69.3B
$3K ﹤0.01%
+400
New +$2.96K
EVTC icon
1771
Evertec
EVTC
$1.78B
$3K ﹤0.01%
100
– –
EYE icon
1772
National Vision
EYE
$1.81B
$3K ﹤0.01%
+100
New +$2.62K
GLW icon
1773
PUT
Corning
GLW
$143B
$3K ﹤0.01%
100
– –
J icon
1774
Jacobs Solutions
J
$17B
$3K ﹤0.01%
46
-417
-90% -$28.1K
JDST icon
1775
CALL
Direxion Daily Junior Gold Miners Index Bear 2X ETF
JDST
$20.1M
$3K ﹤0.01%
+1
New +$5.46K
69 70
71
72 73

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Prelude Capital Management held 2,419 positions worth $1.82B, up 22% from $1.49B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Prelude Capital Management withdrew a net $120M in Q2 2020, closing 497 positions and reducing 305 holdings. Its most notable exit was Allergan plc, an estimated $16.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in iShares 0-5 Year High Yield Corporate Bond ETF worth $24.4M.

  • Prelude Capital Management's largest Q2 2020 buy was iShares 0-5 Year High Yield Corporate Bond ETF: 568,440 shares worth $24.4M.
  • Prelude Capital Management added most to Acacia Communications Inc in Q2 2020, an estimated $3.72M increase.
  • Prelude Capital Management's biggest Q2 2020 reduction was Micron Technology, cutting an estimated $8.71M.
  • Prelude Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $16.1M.
  • Prelude Capital Management's ten largest holdings make up 36% of its $1.82B portfolio in Q2 2020.
  • Prelude Capital Management opened 1,036 new positions and closed 497 in Q2 2020.
  • Prelude Capital Management's portfolio value rose 22% quarter-over-quarter to $1.82B.

Based on Prelude Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.